PASQUALUCCI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 2.173
EU - Europa 1.932
AS - Asia 593
SA - Sud America 6
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.708
Nazione #
US - Stati Uniti d'America 2.164
IE - Irlanda 479
UA - Ucraina 443
IT - Italia 338
SE - Svezia 256
HK - Hong Kong 221
VN - Vietnam 198
FI - Finlandia 102
DE - Germania 95
CN - Cina 91
RU - Federazione Russa 87
TR - Turchia 57
GB - Regno Unito 39
BE - Belgio 20
CH - Svizzera 18
FR - Francia 14
PL - Polonia 13
AT - Austria 8
LB - Libano 8
GR - Grecia 7
NL - Olanda 7
SG - Singapore 7
UZ - Uzbekistan 5
BR - Brasile 4
KR - Corea 4
CA - Canada 3
MX - Messico 3
PA - Panama 3
AR - Argentina 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EU - Europa 2
IN - India 2
ES - Italia 1
LU - Lussemburgo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.708
Città #
Dublin 479
Chandler 434
San Mateo 248
Jacksonville 247
Hong Kong 221
Dong Ket 197
Altamura 135
Perugia 123
Medford 115
Princeton 112
Ann Arbor 97
Lawrence 90
Wilmington 83
Andover 66
Izmir 53
Des Moines 42
Beijing 39
Saint Petersburg 38
Norwalk 26
Ashburn 25
Boardman 21
Brussels 20
Falls Church 19
Woodbridge 17
Amelia 16
New York 14
West Jordan 14
San Paolo di Civitate 12
Helsinki 11
Los Angeles 11
Dearborn 10
Redwood City 8
Nanning 7
Chicago 6
Moscow 6
Redmond 6
Shanghai 6
Den Haag 5
Frankfurt Am Main 5
Jamaica 5
Philadelphia 5
Auburn Hills 4
Houston 4
San Diego 4
Seoul 4
Singapore 4
Athens 3
Istanbul 3
Modena 3
Panama City 3
Simi Valley 3
Cambridge 2
Carbonia 2
Corona 2
Fairfield 2
Foligno 2
Lausanne 2
Mar del Plata 2
Ottawa 2
Shaoxing 2
Vienna 2
Warsaw 2
Boydton 1
Bratislava 1
Buffalo 1
Dallas 1
Edinburgh 1
Florence 1
Galliate 1
Genoa 1
Guangzhou 1
Hangzhou 1
Hanoi 1
Hanover 1
Hereford 1
Kocaeli 1
London 1
Luton 1
Luxembourg 1
Madrid 1
Mainz 1
Massa 1
Milan 1
Monte Santo 1
Mountain View 1
Nanjing 1
Palermo 1
Pikermi 1
Prata Di Pordenone 1
Rome 1
San Giuliano Milanese 1
Serio 1
São Paulo 1
Tappahannock 1
Terni 1
The Bronx 1
Toronto 1
Wayne 1
Zhengzhou 1
Zurich 1
Totale 3.189
Nome #
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 102
A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. 93
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 90
BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. 85
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma 79
Lack of the ubiquitin-editing enzyme A20 results in loss of hematopoietic stem cell quiescence 78
Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. 75
Comparison of immunosuppressive effects of single-dose and hyperfractionated total body irradiation 74
The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. 72
Analysis of the coding genome of diffuse large B cell lymphoma 72
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 71
Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma. 69
Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation. 68
Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. 67
BCL-6 in aids-related lymphomas: pathogenetic and histogenetic implications. 66
Alterations of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 66
Aberrant somatic hypermutation in tumor cells of nodular lymphocyte-predominant and classical Hodgkin's lymphoma. 61
Bcl-6 protein expression in normal and neoplastic lymphoid tissues. 61
BCL-6 mutations are associated with immunoglobulin variable heavy chain mutations in B-cell chronic lymphocytic leukemia. 61
AID is required for germinal center-derived lymphomagenesis. 60
B-cell receptor signaling derailed in lymphomas. 59
BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. 59
The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations. 59
BRAF mutations in hairy-cell leukemia. 59
Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders. 56
Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. 56
Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma. 54
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML) 54
Proto-oncogenes and Tumor Suppressor Genes in Hematopoietic Malignancies 53
Analysis of a 69-kb contiguous genomic sequence at a putative tumor suppressor gene locus on human chromosome 6q27. 53
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 53
Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology. 52
The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3ß inhibition 52
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma. 51
Expression of the AID protein in normal and neoplastic B cells. 51
Whole-Exome Sequencing Identifies Recurrent Mutations of BCOR in Acute Myeloid Leukemia with Normal Karyotype 51
Molecular pathogenesis of germinal center-derived B cell lymphomas 51
Gli anticorpi monoclonali nella terapia delle emopatie maligne. 50
Hypermutation of multiple proto-oncogenes in B-cell Diffuse Large Cell Lymphomas 49
Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region. 49
IMMUNOCYTOCHEMICAL DIAGNOSIS OF ACUTE PROMYELOCYTIC LEUKEMIA (M3) WITH THE ANTI-PROMYELOCYTIC LEUKEMIA (ANTI-PML) MONOCLONAL ANTIBODY PG-M3 48
Inactivating mutations of acetyltransferase genes in B-cell lymphoma. 47
Targeted antibodies in the treatment of lymphomas. 47
Unique and Shared Epigenetic Programs of the CREBBP and EP300 Acetyltransferases in Germinal Center B Cells Reveal Targetable Dependencies in Lymphoma 47
NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin? 46
Protein expression analysis of chromosome 12 candidate genes in chronic lymphocytic leukemia (CLL). 46
Pathology and Molecular Pathogenesis of DLBCL and Related Entities 46
Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. 43
Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimens. 41
Molecular Biology of Lymphoma 40
BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma. 40
The genetics of nodal marginal zone lymphoma 40
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. 39
Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. 39
Mutations in the RNA splicing factor SF3B1 promote tumorigenesis through MYC stabilization 39
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype 38
The CREBBP acetyltransferase is a haploinsufficient tumor suppressor in B-cell lymphoma 38
Combined genetic inactivation of beta2-microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma 38
Towards patient-based cancer therapeutics. 37
Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. 36
CD30+ anaplastic large-cell lymphoma, null type, with signet-ring appearance. 36
Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease. 36
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. 36
Genetics of follicular lymphoma transformation. 36
Molecular Biology of Lymphoma 36
PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells. 35
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML). 35
Repurposing Dasatinib for diffuse large B cell lymphoma. 35
BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma. 34
Molecular pathogenesis of B cell malignancy: the role of BCL-6. 34
Immunotoxin therapy of hematological malignancies. 34
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype 34
Molecular pathogenesis of diffuse large B-cell lymphoma 34
Genomic analysis of non-splenic marginal zone lymphomas (MZL) indicates similarities between nodal and extranodal MZL and supports their derivation from memory B-cells 33
An oncogenic role for alternative NF-κB signaling in DLBCL revealed upon deregulated BCL6 expression 33
Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML). 32
State of the Art and Future Needs in Cytogenetic/Molecular Genetics/Arrays in childhood lymphoma: summary report of workshop at the First International Symposium on childhood and adolescent non-Hodgkin lymphoma, April 9, 2003, New York City, NY. 32
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. 32
Evaluation of immunotoxins containing single-chain ribosome-inactivating proteins and an anti-CD22 monoclonal antibody (OM124): in vitro and in vivo studies. 31
MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis 31
Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program 30
New approaches to lymphoma diagnosis. 30
Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness. 30
Emerging epigenetic-modulating therapies in lymphoma 30
Single-cell analysis of germinal-center B cells informs on lymphoma cell of origin and outcome 29
Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. 29
Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. 29
Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis 29
Genetics of diffuse large b-cell lymphoma 29
Molecular pathogenesis of non-Hodgkin's lymphoma: the role of Bcl-6. 28
Fractal-like distributions over the rational numbers in high-throughput biological and clinical data. 28
Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). 27
Dissecting KMT2D missense mutations in Kabuki syndrome patients 27
Molecular Genetics of Lymphoma 24
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. 23
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia. 23
Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome. 23
Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia 23
MutComFocal: an integrative approach to identifying recurrent and focal genomic alterations in tumor samples. 23
Molecular pathogenesis of non-Hodgkin's lymphoma: the role of Bcl-6. Leuk Lymphoma. 23
Totale 4.592
Categoria #
all - tutte 18.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.939


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201966 0 0 0 0 0 0 0 0 0 0 63 3
2019/2020368 3 9 62 4 66 5 65 5 85 19 27 18
2020/20211.025 9 74 36 73 284 44 67 6 112 28 75 217
2021/2022954 24 178 14 61 42 11 14 288 16 35 124 147
2022/20231.591 124 312 22 144 93 169 1 70 600 4 41 11
2023/2024487 33 50 31 11 4 5 174 9 96 31 43 0
Totale 4.935